Official registry condition

Recurrent Meningioma peptide trials

3 selected ClinicalTrials.gov records carrying the official condition label Recurrent Meningioma. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.

Registry records

3 selected records.

Connected peptides

2 profiles.

Registry update years

2026–2026 in selected records.

Indication intelligence

Selected evidence landscape

Trial phases2

Phase labels copied from the retained ClinicalTrials.gov versions.

Registry statuses1

Overall statuses at each retained observation, not necessarily current today.

Across the connected peptide profiles, PeptideScanner also carries 16 selected PubMed records and 4 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Recurrent Meningioma unless their own cited source says so.

Collection change ledger

Recently changed records on this condition hub

All recent changes →

These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.

Record added

ClinicalTrials.gov record NCT04082520

PeptideScanner retained ClinicalTrials.gov record NCT04082520 at 2026-11-16T01:36:36.861Z. Its registry update date was 2026-10-13, and PeptideScanner's reviewed identity mapping was lutetium-lu-177-dotatate.

PeptideScanner change date
November 16, 2026
Cited source date
October 13, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT06326190

PeptideScanner retained ClinicalTrials.gov record NCT06326190 at 2026-11-16T01:36:36.861Z. Its registry update date was 2026-06-15, and PeptideScanner's reviewed identity mapping was lutetium-lu-177-dotatate.

PeptideScanner change date
November 16, 2026
Cited source date
June 15, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT07150806

PeptideScanner retained ClinicalTrials.gov record NCT07150806 at 2026-11-16T17:36:42.191Z. Its registry update date was 2026-08-13, and PeptideScanner's reviewed identity mapping was gallium-ga-68-dotatate.

PeptideScanner change date
November 16, 2026
Cited source date
August 13, 2026
Evidence lane
Clinical trials

Attributed registry records

Selected records

All trial facets →